Integrated pan-cancer profiling highlights OSR2 as a prognostic indicator and immune-associated biomarker
Lei Tang, Qiqi Chen, Chunmiao Han, Yuanyuan Wang, Jianbo Li, Yunsong Liu · 2026
Read Integrated pan-cancer profiling highlights OSR2 as a prognostic indicator and immune-associated biomarker by Lei Tang, Qiqi Chen, Chunmiao Han, Yuanyuan Wang, Jianbo Li, Yunsong Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13538303.txt.
Description
Lei Tang and co-authors profile a gene called OSR2 across many cancers in a 2026 combined database study. The gene has been tied to killer T cell exhaustion inside tumors, hinting at a drug target, yet its wider cancer picture was unmapped. Data from tumor, normal tissue, and protein collections supplied expression, survival, gene change, immune, and drug response checks across cancer types.
Expression ran high or low depending on cancer type and stage, with gene copy and chemical tagging changes tracking abnormal levels closely. Survival links flipped direction by cancer type, acting as risk in some cancers and protection in others. Expression also tracked immune cell entry, checkpoint genes, mutation load, and drug sensitivity. The authors propose OSR2 as a candidate marker for immune therapy research.
Catalog record
| CREATOR | Lei Tang, Qiqi Chen, Chunmiao Han, Yuanyuan Wang, Jianbo Li, Yunsong Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55497 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |